Compumedics Limited provided earnings guidance for the year 2022. For the year, the company expects sales orders taken for FY22 expected to be at least $42 million, an, at least, 19% increase on FY21. Revenues expected to be around $35 million for FY22.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 AUD | +10.64% | +8.33% | -7.14% |
23/05 | Compumedics on Track to Reach Record Revenue in 2024, But Warns of Earnings Miss | MT |
29/02 | Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.14% | 3.05Cr | |
+10.03% | 22TCr | |
+13.59% | 19TCr | |
+20.01% | 14TCr | |
+30.83% | 11TCr | |
+2.05% | 6.5TCr | |
+15.38% | 5.3TCr | |
+3.96% | 5.04TCr | |
+8.37% | 4.42TCr | |
+3.27% | 3.64TCr |
- Stock Market
- Equities
- CMP Stock
- News Compumedics Limited
- Compumedics Limited Provides Earnings Guidance for the Year 2022